ENTITY
Amarin Corporation Plc

Amarin Corporation Plc (AMRN US)

10
Analysis
Health CareUnited States
Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.
more
24 Sep 2023 16:47

Lotus Pharmaceutical (1795 TT): Continued Stellar Growth in Q2; Pipeline Expansion to Drive Growth

​Lotus saw 53% YoY revenue growth in 2Q23, driven Lenalidomide and Suboxone in the US and branded products in Taiwan. EPS exceeded expectations....

Logo
404 Views
Share
bullishCSL Ltd
15 Jun 2023 18:12

CSL Ltd (CSL AU): FY23 Guidance Cut Drags Near-Term Prospect; Long-Term Growth Drivers Still Intact

CSL reduced FY23 profit projection due to higher-than-anticipated Fx headwind of $230–250M from $175M. Strong demand for existing products and new...

Logo
379 Views
Share
bullishS&P 500 INDEX
12 Dec 2019 21:11

U. S. Equity Strategy: Small-Caps Closing the Gap

Major averages in the US (S&P 500, Dow, Russell 2000) and Europe (STOXX 600 & 50) each had throwbacks to their prior breakout levels last...

Logo
441 Views
Share
25 Mar 2019 06:47

Amarin--Our Talks With The CEO & An Update on New Trial Data Released at ACC Conference

Strong Q1 to Come: We recently had a call with Amarin's CEO, John Thero, and update our model with quarterly estimates. Q1 should see revenue...

Logo
2.6k Views
Share
28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
689 Views
Share
x